Novan Inc (NOVN)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-06-27 | 2023-06-27 | S Sale | Non-Executive Director |
11,553
-31.4%
0.41USD 4,716 |
11,553 -31.4% | 0.41 | USD 4,716 | |
| 2022-04-11 | 2022-04-07 | B Purchase | Non-Executive Director |
1,000
+33.3%
3.45USD 3,449 |
1,000 +33.3% | 3.45 | USD 3,449 | |
| 2022-03-30 | 2022-03-28 | B Purchase | Non-Executive Director |
1,000
+50.0%
3.45USD 3,450 |
1,000 +50.0% | 3.45 | USD 3,450 | |
| 2022-03-28 | 2022-03-25 | B Purchase | Non-Executive Director |
2,000
+inf%
3.55USD 7,090 |
2,000 +inf% | 3.55 | USD 7,090 | |
| 2022-03-22 | 2022-03-18 | B Purchase |
Chief Financial Officer Officer |
1,000
+66.7%
3.50USD 3,500 |
1,000 +66.7% | 3.50 | USD 3,500 | |
| 2022-03-22 | 2022-03-18 | B Purchase | Non-Executive Director |
10,000
+16.8%
3.64USD 36,350 |
10,000 +16.8% | 3.64 | USD 36,350 | |
| 2022-03-18 | 2022-03-17 | B Purchase | Non-Executive Director |
5,000
+9.2%
3.34USD 16,705 |
5,000 +9.2% | 3.34 | USD 16,705 | |
| 2022-03-18 | 2022-03-16 | B Purchase | Non-Executive Director |
5,000
+10.1%
3.34USD 16,685 |
5,000 +10.1% | 3.34 | USD 16,685 | |
| 2021-03-29 | 2021-03-26 | B Purchase |
President and CEO Executive Director |
70,000
+86.7%
1.43USD 100,100 |
70,000 +86.7% | 1.43 | USD 100,100 | |
| 2020-03-05 | 2020-03-03 | B Purchase | Non-Executive Director |
200,000
0.00USD 0 |
200,000 | 0.00 | USD 0 | |
| 2020-03-05 | 2020-03-03 | B Purchase | Non-Executive Director |
7,000
0.00USD 0 |
7,000 | 0.00 | USD 0 | |
| 2019-07-02 | 2019-07-02 | S Sale |
Malin Life Sciences Holdings Ltd Large shareholder |
6,287
-0.2%
2.75USD 17,289 |
6,287 -0.2% | 2.75 | USD 17,289 | |
| 2019-07-02 | 2019-07-01 | S Sale |
Malin Life Sciences Holdings Ltd Large shareholder |
913
-0.0%
2.74USD 2,502 |
913 -0.0% | 2.74 | USD 2,502 | |
| 2019-07-02 | 2019-06-28 | S Sale |
Malin Life Sciences Holdings Ltd Large shareholder |
17,800
-0.7%
2.69USD 47,882 |
17,800 -0.7% | 2.69 | USD 47,882 | |
| 2019-05-30 | 2019-05-29 | B Purchase |
Chief Executive Officer Executive Director |
1,500
+3.4%
1.97USD 2,955 |
1,500 +3.4% | 1.97 | USD 2,955 | |
| 2019-05-29 | 2019-05-28 | B Purchase |
Chief Executive Officer Executive Director |
3,500
+8.8%
2.15USD 7,525 |
3,500 +8.8% | 2.15 | USD 7,525 | |
| 2019-05-29 | 2019-05-24 | B Purchase | Non-Executive Director |
20,000
+7.3%
2.20USD 44,000 |
20,000 +7.3% | 2.20 | USD 44,000 | |
| 2019-05-23 | 2019-05-22 | B Purchase | Non-Executive Director |
50,000
+41.7%
2.21USD 110,500 |
50,000 +41.7% | 2.21 | USD 110,500 | |
| 2019-05-23 | 2019-05-21 | B Purchase |
5,000
+46.2%
1.90USD 9,500 |
5,000 +46.2% | 1.90 | USD 9,500 | ||
| 2019-05-21 | 2019-05-20 | B Purchase |
President and COO Executive Director |
80,000
+11544.0%
1.92USD 153,600 |
80,000 +11544.0% | 1.92 | USD 153,600 | |
| 2019-05-21 | 2019-05-17 | B Purchase |
Chief Executive Officer Executive Director |
40,000
+inf%
1.43USD 57,200 |
40,000 +inf% | 1.43 | USD 57,200 | |
| 2019-05-21 | 2019-05-17 | B Purchase |
Chief Executive Officer Executive Director |
20,000
+50.0%
1.43USD 28,600 |
20,000 +50.0% | 1.43 | USD 28,600 | |
| 2019-05-21 | 2019-05-17 | B Purchase |
VP, Finance & Corp. Controller |
14,900
+14900.0%
1.50USD 22,350 |
14,900 +14900.0% | 1.50 | USD 22,350 | |
| 2019-05-21 | 2019-05-17 | B Purchase |
VP, Accounting and Bus Ops |
5,400
+415.4%
1.47USD 7,938 |
5,400 +415.4% | 1.47 | USD 7,938 | |
| 2019-05-21 | 2019-05-17 | B Purchase |
President and COO Executive Director |
693
+inf%
1.49USD 1,033 |
693 +inf% | 1.49 | USD 1,033 | |
| 2018-10-01 | 2018-09-28 | B Purchase |
INGRAM ROBERT ALEXANDER Non-Executive Director |
50,000
+71.7%
2.84USD 142,000 |
50,000 +71.7% | 2.84 | USD 142,000 | |
| 2018-09-27 | 2018-09-26 | B Purchase |
Martin G. Kelly Chief Executive Officer Executive Director |
10,000
+33.3%
2.73USD 27,300 |
10,000 +33.3% | 2.73 | USD 27,300 | |
| 2018-08-24 | 2018-08-22 | B Purchase | Non-Executive Director |
20,000
+7.9%
2.66USD 53,200 |
20,000 +7.9% | 2.66 | USD 53,200 | |
| 2018-08-23 | 2018-08-21 | B Purchase |
Martin G. Kelly Chief Executive Officer Executive Director |
30,000
+inf%
2.71USD 81,300 |
30,000 +inf% | 2.71 | USD 81,300 | |
| 2017-08-29 | 2017-08-29 | B Purchase |
INGRAM ROBERT ALEXANDER |
8,465
+13.8%
4.70USD 39,786 |
8,465 +13.8% | 4.70 | USD 39,786 | |
| 2017-08-29 | 2017-08-25 | B Purchase |
INGRAM ROBERT ALEXANDER |
3,535
+6.1%
4.25USD 15,024 |
3,535 +6.1% | 4.25 | USD 15,024 | |
| 2017-08-25 | 2017-08-23 | B Purchase |
12,000
+5.0%
3.99USD 47,880 |
12,000 +5.0% | 3.99 | USD 47,880 | ||
| 2016-09-28 | 2016-09-26 | B Purchase |
Malin Life Sciences Holdings Ltd Large shareholder |
800,000
+43.9%
11.00USD 8,800,000 |
800,000 +43.9% | 11.00 | USD 8,800,000 |